Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cedb68efb326bd11d0ff575950cd4f7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
filingDate |
2021-03-05^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cebd5c30c22f8a234a07aef4c715240 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_985d7a57b5e9dff2eb11bfe7c6c48a7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c3e384e1b9f6ba72ed3631ba67fbec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770c55649ca3e046e1adf11a3f678a1f |
publicationDate |
2022-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11420955-B2 |
titleOfInvention |
Compounds as neuronal histamine receptor-3 antagonists and uses thereof |
abstract |
The present invention relates compounds of Formula (A) as H3R antagonists, as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of Histamine 3 Receptor (H3R) functions. The present invention also relates to the uses of the compounds or pharmaceutical compositions in treating or preventing certain disorders and diseases which relate to H3R functions in humans. |
priorityDate |
2018-09-30^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |